3D Cell Culture is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique.

With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine.

The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culuture.

• Stefan Przyborski, Professor of Cell Technology, University of Durham
• Louisse Bisset, Senior Biologicals Quality Assessor, MHRA
• Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis
• Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca
• Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations
• Olaf Galuba, Scientist, Novartis
• Christopher Schofield, Investigator, GlaxoSmithKline

See the full speaker line-up at http://www.3D-cellculture.com/euagenda